Axa’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-22,250
| Closed | -$650K | – | 1199 |
|
2022
Q4 | $650K | Hold |
22,250
| – | – | ﹤0.01% | 952 |
|
2022
Q3 | $588K | Sell |
22,250
-3,000
| -12% | -$79.3K | ﹤0.01% | 938 |
|
2022
Q2 | $1.12M | Sell |
25,250
-6,750
| -21% | -$300K | ﹤0.01% | 859 |
|
2022
Q1 | $1.58M | Buy |
+32,000
| New | +$1.58M | ﹤0.01% | 876 |
|